Overview Fundamentals API Earnings EOD API Sample Code Pricing

GB Sciences Inc (GBLX PINK) stock market data APIs

$0.01 0(0%) as of July 19, 2024
Price chart is built with Anychart

GB Sciences, Inc., a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.

GB Sciences Inc Financial Data Overview

3 147 K
406 M
3 121 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'GBLX',
Type: 'Common Stock',
Name: 'GB Sciences Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000CY09M7',
CIK: '1165320',
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

GB Sciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 3 121 K
  • EBITDA -1 579 620
  • Earnings Per Share -0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get GB Sciences Inc Earnings via APIs

  • Latest Release 2024-02-12
  • EPS/Forecast NaN

Get GB Sciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?